Precigen (PGEN) Enterprise Value Growth (1y) (2012 - 2026)
Precigen (PGEN) Enterprise Value Growth (1y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Precigen |
1.58 Bn |
1.58 Bn |
20.69 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-10.89% |
| Dec 31, 2025 |
-40.41% |
| Sep 30, 2025 |
-323.09% |
| Jun 30, 2025 |
-47.78% |
| Mar 31, 2025 |
-13.33% |
| Dec 31, 2024 |
-10.88% |
| Sep 30, 2024 |
-184.15% |
| Jun 30, 2024 |
-18.07% |
| Mar 31, 2024 |
-90.14% |
| Dec 31, 2023 |
-30.41% |
| Sep 30, 2023 |
85.87% |
| Jun 30, 2023 |
85.65% |
| Mar 31, 2023 |
56.50% |
| Dec 31, 2022 |
55.65% |
| Sep 30, 2022 |
37.66% |
| Jun 30, 2022 |
-0.17% |
| Mar 31, 2022 |
48.79% |
| Dec 31, 2021 |
-8.54% |
| Sep 30, 2021 |
-1.16% |
| Jun 30, 2021 |
13.46% |
